[1] |
玉超勇. Graves病研究新进展. 医学综述, 2008, 14(18): 2805-2807. |
[2] |
刘艳, 付立武, 魏月芳, 等. 131I与抗甲状腺药物治疗Graves甲亢的疗效评价. 河南科技大学学报(医学版), 2008, 26(4): 265-266. |
[3] |
祝学光. 外科学, 颈部疾病. 5版. 北京: 人民卫生出版社, 2002: 337-338. |
[4] |
陈再君. 131碘治疗甲状腺疾病的研究现状. 临床荟萃, 2004, 19(4): 228-229. |
[5] |
陈华, 宋丁. 131I治疗Graves病甲状腺机能亢进症的5年随访研究. 华西医学, 2008, 23(2): 272-273. |
[6] |
Kraft O, Stepien A. Functional autonomies of thyroid and efficacy of radioiod-ine therapy. Cancer Biother Radiopharm, 2007, 22(2): 261-267. |
[7] |
肖海鹏, 王深明. 甲状腺功能亢进症的临床诊疗思维. 新医学, 2005, 36(1): 53-55. |
[8] |
李林, 沈绍群. 131I固定剂量法治疗甲亢近期疗效观察. 四川大学学报(医学版), 2005, 36(5): 752-753. |
[9] |
熊星辉, 覃伟武. 131I治疗甲亢的进展与现状. 中国临床新医学, 2009, 2(3): 301-303. |
[10] |
Allahabadia A, Daykin J, Sheppard MC, et al. Radioiodinetreatment of hyperthyroidism-prognostic factors for outcome. J Clin Endocrinol Metab, 2001, 86(8): 3611-3617. |
[11] |
戴红, 陈炎斌, 张笑丹, 等. 不同方法治疗Graves病的回顾性对比研究. 武警医学, 2008, 19(8): 693-696. |
[12] |
Jin JH, Zhang XJ, Yu HM, et al. Outcome of radioiodine-131 therapy in Graves disease: A retrospective analysis for 3603 cases. J Nucl Med, 2008, 49(Suppl 1): 89P. |
[13] |
Leslie WD, Ward L, Salamon EA, et al. A randomized comparison of radioiodine doses in Graves'hyperthyroidism. J Clin Endocrinol Metab, 2003, 88(3): 978-983. |
[14] |
龙少康, 王小玲, 梁新蓉, 等. 131I治疗甲亢及引起甲减危险因素的国内外研究概况. 现代预防医学, 2009, 36(5): 991-992. |
[15] |
Shi GM, Xu Q, Zhu CY, et al. Influence of propylthiouracil and methimazole pre-treatment on the outcome of iodine-131 therapy inhyperthyroid patients with Graves'disease. J Int Med Res, 2009, 37(2): 576-582. |
[16] |
El Refaei SM, Shawkat W. Long-term carbimazole intake does not affect success rate of radioactive 131 Iodine in treatment of Graves'hyperthyroidism. Nucl Med Commun, 2008, 29(7): 642-648. |
[17] |
Walter MA, Müller-Brand J, Müller B. Antithyroid drugs and radioiodine and the absence of evidence. J Nucl Med, 2007, 48(8): 1403-1404. |
[18] |
Walter MA, Briel M, Christ-Crain M, et al. Effects of antithyroid drugs on radioiodinetreatment: systematic review and meta-analysis of randomised controlled trials. BMJ, 2007, 334(7594): 514. |
[19] |
郑薇, 谭建, 贾春霞, 等. 抗甲状腺药物对131I治疗Graves病疗效影响. 中外医疗, 2008, 27(7): 3-5. |
[20] |
孙云钢, 蒋宁一. 131I治疗Gravese'病的临床应用进展. 中国医疗前沿, 2009, 4(4): 26-28. |
[21] |
Rivkees S. Radioactive iodine use in childhood Graves'disease: time to wake up and smell the I-131. J Clin Endocrinol Metab, 2004, 89(9): 4227-4228. |
[22] |
Franklyn JA, Sheppard MC, Maisonneuve P. Thyroid function and mortality in patients treated for hyperthyroidism. JAMA, 2005, 294(1): 71-80. |
[23] |
Franklyn JA, Maisonneuve P, Sheppard M, et al. Cancer incidence and mortality after radioiodine treatment for hyperthyroidism: a population-based cohort study. Lancet, 1999, 353(9170): 2111-2115. |
[24] |
Ceccarelli C, Canale D, Vitti P. Radioactive iodine(131I)effects on male fertility. Curr Opin Urol, 2008, 18(6): 598-601. |